At what bilirubin level on liver function tests should anti‑tubercular therapy be discontinued?

Stop Anti-Tubercular Therapy When Bilirubin Rises Above Normal

Stop rifampicin, isoniazid, and pyrazinamide immediately if bilirubin rises above the upper limit of normal, regardless of the absolute value. 1

The Critical Threshold

The British Thoracic Society guidelines are unequivocal: any rise in bilirubin level is an indication to stop the hepatotoxic anti-TB drugs (rifampicin, isoniazid, and pyrazinamide). 1 This is a lower threshold than for transaminases alone, which require elevation to 5 times the upper limit of normal before stopping treatment.

The European Respiratory Society guidelines reinforce this approach, stating that "a rise in bilirubin should lead to discontinuation of these drugs" when managing TB treatment in patients with liver function abnormalities. 2

Why Bilirubin Elevation Matters More

Elevated bilirubin indicates more severe hepatocellular injury with impaired hepatic excretory function, not just hepatocyte inflammation. This represents a qualitatively different and more dangerous form of liver injury than isolated transaminase elevation. The guidelines recognize this by setting a much lower threshold for bilirubin compared to ALT/AST.

The Complete Algorithm for Stopping ATT

Stop all hepatotoxic drugs (rifampicin, isoniazid, pyrazinamide) if:

• Bilirubin rises above normal (any elevation)
• AST/ALT rises to 5× upper limit of normal in asymptomatic patients
• AST/ALT rises to 3× upper limit of normal with hepatitis symptoms (fever, malaise, vomiting, jaundice)
• Clinical jaundice appears, regardless of lab values

1, 3

What to Do After Stopping

For non-infectious or mildly ill patients: Wait until liver function normalizes completely before reintroducing drugs. No treatment is needed during this period. 1

For severely ill or smear-positive patients: Switch immediately to non-hepatotoxic drugs (streptomycin and ethambutol) as inpatient therapy until liver function normalizes. 1

Drug Reintroduction Protocol

Once liver function returns to normal, reintroduce drugs sequentially with daily monitoring:

1. Isoniazid first: Start 50 mg/day → increase to 300 mg/day over 2-3 days
2. Rifampicin second: Start 75 mg/day → 300 mg → full dose (450-600 mg based on weight) over 6-9 days
3. Pyrazinamide last: Start 250 mg/day → 1.0 g → full dose (1.5-2.0 g based on weight)

Monitor liver function daily during reintroduction. If hepatotoxicity recurs, identify and permanently exclude the offending drug. 1

Common Pitfall to Avoid

Do not continue treatment hoping bilirubin will normalize on its own. The CDC guidelines on rifampin-pyrazinamide for latent TB specifically state that treatment should be discontinued immediately if "serum bilirubin concentration greater than the normal range, whether or not symptoms are present." 4 This zero-tolerance approach to bilirubin elevation reflects the serious risk of progression to acute liver failure.

The 2016 ATS/CDC/IDSA guidelines confirm this approach, noting that drug-induced liver injury is suspected when bilirubin elevation occurs alongside other liver test abnormalities, and hepatotoxic drugs should be stopped immediately. 3